StockData
Bausch Health Companies Inc. logo

Bausch Health Companies Inc. (BHC) stock

BHCNYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 8/3075% below fair value
$8.73+0.26 (+3.07%)

Close on Nov 18, 2026Market cap $3.27BP/E –Yield –

Bausch Health Companies pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Bausch Health Companies's pe ratio was 13.6× on Apr 30, 2026, against 54.2× a year earlier. Over the last 5 years it ranged from 2.3× to 736.9×, with a median of 51.0×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Apr 30, 202613.6×+6.5
2025Dec 31, 20257.2×−3.8
2023Jan 31, 202311.0×+2.0
2022Dec 30, 20229.0×+6.3
2018Apr 30, 20182.6×−2.7
2017Dec 29, 20175.3×−45.6
2016Jan 29, 201651.0×−6.5
2015Dec 31, 201557.4×−41.3
2014Dec 31, 201498.7×−638.2
2013Jan 31, 2013736.9×+72.8
2012Dec 31, 2012664.1×+451.9
2011Dec 30, 2011212.2×+185.5
2010Jan 29, 201026.8×+1.3
2009Dec 31, 200925.4×–

More Bausch Health Companies figures

See a number that looks wrong?